Osama Bisht

@SriniTummala @SIRRFS @JayMathewsMD @AmputationSuck @_backtable Here’s the fix in action. Punctured the patent CFA, directed the needle about ~2 cm into the occluded SFA , sent V18 down over a CXI. Externalized through the pedal sheath. Therapy from the original retro sheath/access. Luminal crossing on IVUS. All in all about 90 minutes.

Long time in coming! I have been working on this in some capacity starting in 2016, from development to CT core lab work and various other endeavors. Great news for our patients! @Heart_SCCT @ASE360 @onco_cardiology @purviparwani @SCAI @HamidNadira massdevice.com/jenavalve-fda-…

A rare and challenging cardiology case highlights the importance of multimodality imaging and careful clinical assessment in complex structural heart disease. Case report published in European Heart Journal – Case Reports: ow.ly/Er4w50YuAgi A reminder of how detailed imaging and multidisciplinary decision-making remain key in modern cardiology. #CardioTwitter #Cardiology #CardiacImaging #CaseReport #EHJCR #EHJCaseReports @Phiso_de @TJ_Yeo @aayshacader @BoldiKovacsMD @SukritiBanthiya @ANazmiCalik @O_Azizy_MD @saramoscatelli7 @EHJCREiC #CardioX

How can surgeons perform pulmonary valve repair at the time of the Ross procedure and address postimplantation aortic regurgitation? Researchers published a safe and durable strategy in #JTCVS. Log in to your account to read more: doi.org/10.1016/j.jtcv… @VChauvetteMD

Medical therapy works 80M w Severe MR sent for evaluation for MTEER After optimizing GDMT 👉TEE Here comes the difficult part: convincing pt/family procedure unnecessary after being referred for it @djc795 @TCT_ME_ @Abdul_alkindy @RHAAttar @alexsfelixecho @SachinGoelMD

As TAVI expands to younger, lower-risk patients, valve thrombosis is an emerging concern. Detection remains inconsistent, long-term impact unclear, and optimal therapy debated. This review covers mechanisms, prevalence, clinical impact & management. #TAVI #CardioTwitter eurointervention.pcronline.com/article/transc…

RCA CTO PCI ✅Challenging anatomy: • Ambiguous proximal cap • Acute marginal branch at px 🧢 • Moderate calcification • Length ~15–20 mm • bifurcation at dx 🧢 • Good septals + epicardial collaterals #CTO101 #CTOPCI #IVUS #CTO #ComplexPCI #InterventionalCardiology #CathLab #CardioTwitter

#IVUS guided #postCABG #PCI episode 13. #IVL + #OPN #MVD #Calcified #ComplexPCI . #HeartFailure #ChronicKidneyDisease #cardiology #cardiotwitter #InterventionalCardiology #intravascularimaging #superhighpressureballoon @esbrilakis @sbrugaletta @TWilsonMD @evandrofilhobr @dautov_MD @realarainmd @rotamonster @ANazmiCalik @ColletCarlos @RinfretStephane @JWMoses @docjohnnyg @crfheart @MichaelMegalyMD @Laserrman @mirvatalasnag @TIOCongress @iamritu @Abdul_alkindy @aspergian1 @agtruesdell @MohammedAlo @ziadalinyc @Dr_ibrahimHarbi @FranceskAlbs @AlbertoCereda1 @AlkashkariWail @FaustoHerediaDr @GopalKkoduru @NievesGonzalo1 @ZHeart11768530 @MattersoftheH14 @MatthewChungMD @KPujdak @whitfieldlewis6 @raimcsantos @DrNeilGuptaIR @nadig_cardio @Murmur_MD @jedicath @Abdul_alkindy @rickytiago @AlkashkariWail @ShadiYaghi2 @AIU_Medical @ShariqShamimMD @FaustoHerediaDr @NievesGonzalo1 @ShockwaveIVL @sis_medical

This state-of-the-art review outlines current evidence on the mechanisms, prevalence, clinical relevance, and management of TAVI thrombosis and highlights ongoing clinical trials investigating this condition. eurointervention.pcronline.com/article/transc…

#CHIP #LMPCI Calcified stenosis in LM in 85yo male with history of multiply strokes. IVUS> #IVL 3,5mm 120 imp> #Angiosculpt 3,5mm 20 ATM> Stent>POT 4,5 mm>kissing>DCB in CX>NC in LAD>2nd POT>IVUS

We are launching a U.S. multicenter registry studying the UNICORN technique during valve-in-valve TAVR. We are inviting centers with UNICORN cases to collaborate and contribute retrospective cases. Collaborators will be included in resulting abstracts/manuscripts.

Site of coronary artery occlusion in STEMI

The most stenotic bioprosthetic mitral valve I have encountered. Mean transmitral gradient 31 mmHg at HR 74 bpm, EOA of just 0.2 cm². The pt was transferred from OSH in pre-shock. Successful TMViV, no valvular or PVL, mean gradient 3 mm Hg.

Intravascular Imaging- vs Angiography-Guided Complex PCI: 5-Year Outcomes From a Randomized Trial In patients with complex coronary artery lesions undergoing PCI, intravascular imaging guidance reduced the risk of a composite of cardiac death, target vessel–related myocardial infarction, or clinically driven target vessel revascularization at median follow-up of 5.3 years, compared to angiography guidance #Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare @JACCJournals @ACCinTouch @hvanspall @DrMarthaGulati @AndrewJSauer @iamritu @Hragy @biljana_parapid jacc.org/doi/10.1016/j.…

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines 1.Treat dyslipidemia earlier to reduce lifetime exposure to atherogenic lipoproteins; start lifestyle counseling in youth and consider early pharmacotherapy in high-risk individuals (e.g., familial hypercholesterolemia or LDL-C ≥160 mg/dL). 2.Use the PREVENT™ risk equations instead of older models to estimate 10- and 30-year ASCVD risk in adults aged 30–79, applying the CPR approach: Calculate risk, Personalize assessment, and Reclassify if needed (e.g., with CAC). 3.Consider LDL-lowering therapy in primary prevention starting at a 10-year risk of 3–5%, and recommend it more strongly at 5–10%, after clinician–patient discussion. 4.LDL-C and non-HDL-C targets are reintroduced, while maintaining focus on percentage LDL reduction based on ASCVD risk. 5.Apolipoprotein B (ApoB) measurement can help detect residual lipoprotein-related risk, especially in patients with high triglycerides, diabetes, or low LDL-C. 6.Measure Lipoprotein(a) at least once; elevated levels significantly increase ASCVD risk and warrant more intensive LDL-lowering strategies. 7.Coronary artery calcium (CAC) scoring can refine risk assessment and treatment decisions, particularly in men ≥40 and women ≥45 years. 8.LDL-lowering therapy is recommended for adults aged 40–75 with diabetes, CKD stage 3–4, or HIV regardless of LDL-C level. 9.In secondary prevention, stricter targets are recommended: LDL-C <55 mg/dL and non-HDL-C <85 mg/dL for very high-risk patients. 10.Statins remain the foundation of therapy, particularly in patients with elevated triglycerides; additional therapies may be needed for severe hypertriglyceridemia to prevent pancreatitis. #Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare @JACCJournals @ACCinTouch @DLBHATTMD @CMichaelGibson @DrMarthaGulati @hvanspall @AndrewJSauer @ESC_Journals @escardio jacc.org/doi/10.1016/j.…

1/Amiodarone vs lidocaine in shock resistant VF - is amiodarone the winner? #REVIVE2026 @CardioNerds @Gurleen_Kaur96

I don’t always snare an Aveir AR but when I do, I snare the Mediport catheter tip at the same time. #catchandrelease #abbottcardio

Percutaneous closure of mitral paravalvular leak - one of the most challenging procedures in structural intervention.